These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 1911078

  • 21. The oestrogen-progesterone receptor ratio: an indicator of breast cancer evolution.
    Cherubini M, Baxa P, Guarino G.
    Chir Ital; 2002; 54(4):423-8. PubMed ID: 12239750
    [Abstract] [Full Text] [Related]

  • 22. Progesterone receptor status of breast cancer metastases.
    Branković-Magić M, Janković R, Nesković-Konstantinović Z, Nikolić-Vukosavljević D.
    J Cancer Res Clin Oncol; 2002 Jan; 128(1):55-60. PubMed ID: 11862473
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.
    Punglia RS, Kuntz KM, Winer EP, Weeks JC, Burstein HJ.
    Cancer; 2006 Jun 15; 106(12):2576-82. PubMed ID: 16703595
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Immunohistochemical investigation of estrogen and progesterone receptors in breast tumors].
    Ellinidi VN, Anikseeva NV, Goncharova OA, Krasnozhon DA, Fedorov KA.
    Vopr Onkol; 2004 Jun 15; 50(2):234-6. PubMed ID: 15176229
    [Abstract] [Full Text] [Related]

  • 27. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients].
    Aftimos G, Trak-Smayra V, Moacdieh-Rehayel L.
    J Med Liban; 2000 Jun 15; 48(1):8-17. PubMed ID: 10881437
    [Abstract] [Full Text] [Related]

  • 28. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G, Barbareschi M, Doglioni C, Palma PD, Mauri FA, Boracchi P, Bevilacqua P, Caffo O, Morelli L, Verderio P.
    Clin Cancer Res; 1995 Feb 15; 1(2):189-98. PubMed ID: 9815973
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Impact of metastatic estrogen receptor and progesterone receptor status on survival.
    Lower EE, Glass EL, Bradley DA, Blau R, Heffelfinger S.
    Breast Cancer Res Treat; 2005 Mar 15; 90(1):65-70. PubMed ID: 15770528
    [Abstract] [Full Text] [Related]

  • 31. [Estradiol and progesterone receptors in loco-regional breast cancer. Clinical and prognostic correlations].
    Bolla M, Chedin M, Chambaz E, Gabelle P.
    Sem Hop; 1984 Jan 19; 60(2):91-6. PubMed ID: 6322331
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [The criteria of the hormonal sensitivity of breast cancer].
    Dryzhak VI.
    Vopr Onkol; 1992 Jan 19; 38(2):166-73. PubMed ID: 1300701
    [Abstract] [Full Text] [Related]

  • 34. Immunocytochemical determination of estrogen receptor, progesterone receptor, and 1,25-dihydroxyvitamin D3 receptor in breast cancer and relationship to prognosis.
    Berger U, McClelland RA, Wilson P, Greene GL, Haussler MR, Pike JW, Colston K, Easton D, Coombes RC.
    Cancer Res; 1991 Jan 01; 51(1):239-44. PubMed ID: 1846309
    [Abstract] [Full Text] [Related]

  • 35. [Comparative study of single-point method and multipoint method in the measurement of estrogen receptor and progesterone receptor in breast cancer].
    Shen XQ.
    Zhonghua Zhong Liu Za Zhi; 1992 Mar 01; 14(2):112-5. PubMed ID: 1618078
    [Abstract] [Full Text] [Related]

  • 36. [Androgen receptors in primary breast carcinoma. Relation to prognostic factors in comparison with estrogen and progesterone receptors].
    Reiner G, Jakesz R, Kolb R, Kühnl-Brady K, Reiner A, Schemper M, Spona J.
    Dtsch Med Wochenschr; 1988 Jun 03; 113(22):892-7. PubMed ID: 3371221
    [Abstract] [Full Text] [Related]

  • 37. Glutathione S-transferase activity in human breast tumors.
    Colovai AI, Stoica A, Cinca SA, Marin M, Gruia M, Condrea I, Petrescu D, Dutu R.
    Neoplasma; 1992 Jun 03; 39(4):249-54. PubMed ID: 1436238
    [Abstract] [Full Text] [Related]

  • 38. [Inconsistency in quantitation of estrogen receptor and progesterone receptor with dextran charcoal method and enzyme immunoassay].
    Morimoto K, Hasuma T, Koh M, Ohtani S, Kinoshita H.
    Gan To Kagaku Ryoho; 2002 Sep 03; 29(9):1597-605. PubMed ID: 12355945
    [Abstract] [Full Text] [Related]

  • 39. [Cytomorphological grading and hormone receptor status in breast carcinoma. Visual studies of smear preparations].
    Schenck U, Burger G, Jütting U, Eiermann W.
    Dtsch Med Wochenschr; 1986 Dec 19; 111(51-52):1949-53. PubMed ID: 3792219
    [Abstract] [Full Text] [Related]

  • 40. Influence of hormonal status on thermography findings in breast cancer.
    Zore Z, Boras I, Stanec M, Oresić T, Zore IF.
    Acta Clin Croat; 2013 Mar 19; 52(1):35-42. PubMed ID: 23837271
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.